January 15, 2026 - PRESSADVANTAGE - Lucent Vision has published a new educational resource titled “What Practice Offers ...

SpyGlass Pharma has randomized the first patients in its 2 registrational phase 3 clinical trials of the Bimatoprost Drug Pad-IOL System (BIM-IOL System) for the lowering of intraocular pressure (IOP) ...

Consecutive patients with MA50 IOLs placed in the sulcus at the University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA, from 1997 to 2012 were identified. Inclusion criteria included patients ...

—There is no perfect intraocular lens, but matching a patient with the lens that best meets their needs can help reduce postoperative dissatisfaction. Reviewed by Sarju Patel, MD, MPH, MSc, Director ...

Abbott announced that the Food and Drug Administration (FDA) has approved the Tecnis Symfony Intraocular Lenses for the treatment of cataracts. Abbott announced that the Food and Drug Administration ...

Intraocular lenses (IOLs), implanted in the eye as treatment for cataracts or myopia, are a growing global market in an ageing population, one estimated to be worth more than $4.5 billion by 2022.

In addition to existing options, several new lenses in development have shown promise. The Akkolens IOL (Akkolens; Breda, The Netherlands) is an accommodative lens in which two progressive lenses ...

Researchers outline numerous benefits of outfitting recipients of cataract surgery with blue-light filtering artificial intraocular lenses (BLF IOLs), as opposed to non-BLF lenses, in a Clinical ...